We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Common Contracts

117 similar Employment Agreement contracts by Korro Bio, Inc., Dynatrace, Inc., Karuna Therapeutics, Inc., others

EMPLOYMENT AGREEMENT
Employment Agreement • August 30th, 2024 • MBX Biosciences, Inc. • Pharmaceutical preparations

This Employment Agreement (“Agreement”) is made between MBX Biosciences, Inc., a Delaware corporation (the “Company”), and Richard Bartram (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities (the “IPO”) pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Employment Agreement between the Executive and the Company dated March 16, 2022 (the “Prior Agreement”), and (ii) any other offer letter, employment agreement or severance agreement.

EMPLOYMENT AGREEMENT
Employment Agreement • August 30th, 2024 • MBX Biosciences, Inc. • Pharmaceutical preparations

This Employment Agreement (“Agreement”) is made between MBX Biosciences, Inc., a Delaware corporation (the “Company”), and Salomon Azoulay (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities (the “IPO”) pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Employment Agreement between the Executive and the Company dated June 14, 2024 (the “Prior Agreement”), and (ii) any other offer letter, employment agreement or severance agreement.

EMPLOYMENT AGREEMENT
Employment Agreement • August 30th, 2024 • MBX Biosciences, Inc. • Pharmaceutical preparations

This Employment Agreement (“Agreement”) is made between MBX Biosciences, Inc., a Delaware corporation (the “Company”), and P. Kent Hawryluk (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities (the “IPO”) pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Employment Agreement between the Executive and the Company dated July 8, 2020 (the “Prior Agreement”), and (ii) any other offer letter, employment agreement or severance agreement.

SECOND]1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • August 22nd, 2024 • Bicara Therapeutics Inc. • Pharmaceutical preparations • Massachusetts

This [Second]2 Amended and Restated Employment Agreement (“Agreement”) is made between Bicara Therapeutics Inc., a Delaware corporation (the “Company”), and [Name] (the “Executive”), and is effective commencing on [ ] (the “Effective Date”). Except with respect to the Equity Documents and Restrictive Covenants Agreement (both as defined below) and subject to Section 11 below, this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the employment agreement between the Executive and the Company dated [ ], [as amended by the First Amendment to Employment Agreement dated [ ],and the Amended and Restated Employment Agreement dated [ ]]3 (collectively, the “Prior Agreements”), and (ii) any other offer letter, employment agreement or severance agreement.

EMPLOYMENT AGREEMENT
Employment Agreement • June 3rd, 2024 • Rapport Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts

This Employment Agreement (“Agreement”) is made between Rapport Therapeutics, Inc., a Delaware corporation (the “Company”), and Abraham N. Ceesay (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Offer Letter between the Executive and the Company dated December 12, 2022 (the “Prior Agreement”), and (ii) any other offer letter, employment agreement or severance agreement.

EMPLOYMENT AGREEMENT
Employment Agreement • June 3rd, 2024 • Rapport Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts

This Employment Agreement (“Agreement”) is made between Rapport Therapeutics, Inc., a Delaware corporation (the “Company”), and Cheryl Gault (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Offer Letter between the Executive and the Company dated June 29, 2023 (the “Prior Agreement”), and (ii) any other offer letter, employment agreement or severance agreement.

EMPLOYMENT AGREEMENT
Employment Agreement • June 3rd, 2024 • Rapport Therapeutics, Inc. • Pharmaceutical preparations • Michigan

This Employment Agreement (“Agreement”) is made between Rapport Therapeutics, Inc., a Delaware corporation (the “Company”), and Troy Ignelzi(the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Offer Letter between the Executive and the Company dated October 24, 2023 (the “Prior Agreement”), and (ii) any other offer letter, employment agreement or severance agreement.

EMPLOYMENT AGREEMENT
Employment Agreement • May 14th, 2024 • Korro Bio, Inc. • Pharmaceutical preparations • Delaware

This Employment Agreement (“Agreement”) is made between Korro Bio, Inc., a Delaware corporation (“Parent”, and together with its subsidiaries, including Korro Bio Ops, Inc., the “Company”), and Olukemi A. Olugemo, having an address at 10 Indian Rock Road, Wayland, MA 01778 (“Kemi Olugemo”) (the “Executive”) and is effective as of May 13, 2024 (the “Effective Date”).

AVROBIO, INC. EMPLOYMENT AGREEMENT
Employment Agreement • February 14th, 2024 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • Massachusetts

This Employment Agreement (“Agreement”) is made as of the 26th day of January 2022 (the “Effective Date”), between AVROBIO, Inc., a Delaware corporation (the “Company”), and Azadeh Golipour (the “Executive”).

AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • January 30th, 2024 • Triller Corp. • Services-computer programming, data processing, etc. • California

This Amended and Restated Employment Agreement (“Agreement”) is made between Triller Platform Inc., a Delaware corporation with its headquarters located at 2121 Avenue of the Stars, Suite 2350, Los Angeles, California, 90067 (the “Company”), and Prem Parameswaran, residing at 3 Sycamore Court, Purchase, NY 10577 (the “Executive”). The Agreement is effective as of December 7, 2023 (the “Effective Date”) and with certain parts being effective as of the closing of the Company’s first public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Employment Agreement between the Executive and the Company dated on or around April 2022 (the “P

EMPLOYMENT AGREEMENT
Employment Agreement • January 30th, 2024 • Triller Corp. • Services-computer programming, data processing, etc. • California

This Employment Agreement (“Agreement”) is made between Triller Corp., a Delaware corporation (the “Company”), and _____________________ (the “Executive”) and is effective as of the closing of the Company’s first public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the [Employment Agreement] between the Executive and the Company dated ______ (the “Prior Agreement”), and (ii) any offer letter, employment agreement or severance agreement.

SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • December 22nd, 2023 • Karuna Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts

This Second Amended and Restated Employment Agreement (“Agreement”) is made between Karuna Therapeutics, Inc., a Delaware corporation (the “Company”), and Andrew Miller, Ph.D. (the “Executive”) and is made effective as of December 22, 2023 (the “Effective Date”).

SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • December 22nd, 2023 • Karuna Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts

This Second Amended and Restated Employment Agreement (“Agreement”) is made between Karuna Therapeutics, Inc., a Delaware corporation (the “Company”), and Jason Brown (the “Executive”) and is made effective as of December 22, 2023 (the “Effective Date”).

AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • December 22nd, 2023 • Karuna Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts

This Amended and Restated Employment Agreement (“Agreement”) is made between Karuna Therapeutics, Inc., a Delaware corporation (the “Company”), and William Meury (the “Executive”) and is made effective as of December 22, 2023 (the “Effective Date”).

SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • December 22nd, 2023 • Karuna Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts

This Second Amended and Restated Employment Agreement (“Agreement”) is made between Karuna Therapeutics, Inc., a Delaware corporation (the “Company”), and Stephen Brannan, M.D. (the “Executive”) and is made effective as of December 22, 2023 (the “Effective Date”).

EMPLOYMENT AGREEMENT
Employment Agreement • December 1st, 2023 • Korro Bio, Inc. • Pharmaceutical preparations • Delaware

This Employment Agreement (“Agreement”) is made between Korro Bio, Inc., a Delaware corporation (“Parent”, and together with its subsidiaries, including Korro Bio Ops, Inc., the “Company”), and Shelby Walker (the “Executive”) and is effective as of the date it is fully executed (the “Effective Date”). Except with respect to the Equity Documents (as defined below) and subject to Section 12, this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Employment Agreement between the Executive and the Company dated March 29, 2023 (the “Prior Agreement”), and (ii) any other offer letter, employment agreement or severance agreement.

EMPLOYMENT AGREEMENT
Employment Agreement • December 1st, 2023 • Korro Bio, Inc. • Pharmaceutical preparations • Delaware

This Employment Agreement (“Agreement”) is made between Korro Bio, Inc., a Delaware corporation (“Parent”, and together with its subsidiaries, including Korro Bio Ops, Inc., the “Company”), and Steven Colletti, Ph.D. (the “Executive”) and is effective as of the date it is fully executed (the “Effective Date”). Except with respect to the Equity Documents (as defined below) and subject to Section 12, this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Employment Agreement between the Executive and the Company dated January 20, 2023 (the “Prior Agreement”), and (ii) any other offer letter, employment agreement or severance agreement.

EMPLOYMENT AGREEMENT
Employment Agreement • December 1st, 2023 • Korro Bio, Inc. • Pharmaceutical preparations • Delaware

This Employment Agreement (“Agreement”) is made between Korro Bio, Inc., a Delaware corporation (“Parent”, and together with its subsidiaries, including Korro Bio Ops, Inc., the “Company”), and Todd Chappell (the “Executive”) and is effective as of the date it is fully executed (the “Effective Date”). Except with respect to the Equity Documents (as defined below) and subject to Section 12, this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Employment Agreement between the Executive and the Company dated March 3, 2021 (the “Prior Agreement”), and (ii) any other offer letter, employment agreement or severance agreement.

EMPLOYMENT AGREEMENT
Employment Agreement • November 14th, 2023 • Korro Bio, Inc. • Pharmaceutical preparations • Delaware

This Employment Agreement (“Agreement”) is made between Korro Bio, Inc., a Delaware corporation (“Parent”, and together with its subsidiaries, including Korro Bio Ops, Inc., the “Company”), and Vineet Agarwal (the “Executive”) and is effective as of the date it is fully executed (the “Effective Date”). Except with respect to the Equity Documents (as defined below) and subject to Section 12, this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Employment Agreement between the Executive and the Company dated March 12, 2021 (the “Prior Agreement”), and (ii) any other offer letter, employment agreement or severance agreement.

EMPLOYMENT AGREEMENT
Employment Agreement • November 14th, 2023 • Korro Bio, Inc. • Pharmaceutical preparations • Delaware

This Employment Agreement (“Agreement”) is made between Korro Bio, Inc., a Delaware corporation (“Parent”, and together with its subsidiaries, including Korro Bio Ops, Inc., the “Company”), and Ram Aiyar, Ph.D. (the “Executive”) and is effective as of the date it is fully executed (the “Effective Date”). Except with respect to the Equity Documents (as defined below) and subject to Section 12, this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Employment Agreement between the Executive and the Company dated October 13, 2020 (the “Prior Agreement”), and (ii) any other offer letter, employment agreement or severance agreement.

EMPLOYMENT AGREEMENT
Employment Agreement • August 7th, 2023 • Allurion Technologies, Inc. • Surgical & medical instruments & apparatus • Massachusetts

This Employment Agreement (“Agreement”) is made between Allurion Technologies, Inc., a Delaware corporation (the “Company”), and Ram Chuttani, M.D. (the “Executive”) and is made effective as of the closing of the transactions contemplated by that certain Business Combination Agreement, dated as of February 9, 2023, by and between the Company, Compute Health Acquisition Corp (“CPUH”), Allurion Technologies Holdings, Inc. (“New Allurion”) and certain other specified parties thereto (the “Business Combination Agreement”). Except with respect to the Restrictive Covenants and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company and any of its subsidiaries regarding the subject matter herein, including, without limitation, the Employment Agreement, effective November 1, 2017, by and between the Company and the Executive (the “Prior Agreement”).

EMPLOYMENT AGREEMENT
Employment Agreement • August 7th, 2023 • Allurion Technologies, Inc. • Surgical & medical instruments & apparatus • Massachusetts

This Employment Agreement (“Agreement”) is made between Allurion Technologies, Inc., a Delaware corporation (the “Company”), and Chris Geberth (the “Executive”) and is made effective as of the closing of the transactions contemplated by that certain Business Combination Agreement, dated as of February 9, 2023, by and between the Company, Compute Health Acquisition Corp (“CPUH”), Allurion Technologies Holdings, Inc. (“New Allurion”) and certain other specified parties thereto (the “Business Combination Agreement”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company and any of its subsidiaries regarding the subject matter herein, including, without limitation, the Offer Letter, dated October 23, 2020, by and between the Company and the Executive (the “Prior Agreement”).

EMPLOYMENT AGREEMENT
Employment Agreement • August 7th, 2023 • Allurion Technologies, Inc. • Surgical & medical instruments & apparatus • Massachusetts

This Employment Agreement (“Agreement”) is made between Allurion Technologies, Inc., a Delaware corporation (the “Company”), and Shantanu Gaur, M.D. (the “Executive”) and is made effective as of the closing of the transactions contemplated by that certain Business Combination Agreement, dated as of February 9, 2023, by and between the Company, Compute Health Acquisition Corp (“CPUH”), Allurion Technologies Holdings, Inc. (“New Allurion”) and certain other specified parties thereto (the “Business Combination Agreement”). Except with respect to the Restrictive Covenants and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company and any of its subsidiaries regarding the subject matter herein, including, without limitation, the Employment Agreement, effective January 1, 2017, by and between the Company and the Executive (the “Prior Agreement”).

EMPLOYMENT AGREEMENT
Employment Agreement • August 2nd, 2023 • Dynatrace, Inc. • Services-prepackaged software • Massachusetts

This Employment Agreement (this “Agreement”) is made as of June 1, 2023 between Dynatrace LLC, a Delaware limited liability company, Dynatrace, Inc., a Delaware corporation that is the parent of Dynatrace LLC (“Parent”), and Daniel Zugelder (the “Executive”), and is effective as of the date the Executive commences employment with Dynatrace LLC, which shall be no later than July 5, 2023 (the “Effective Date”). Dynatrace LLC, Parent and their respective subsidiaries and other controlled affiliates are collectively referred to herein as the “Company,” and the duties of the Company set forth in this Agreement may be discharged by any entity within that definition.

EMPLOYMENT AGREEMENT
Employment Agreement • June 27th, 2023 • Allurion Technologies Holdings, Inc. • Surgical & medical instruments & apparatus • Massachusetts

This Employment Agreement (“Agreement”) is made between Allurion Technologies, Inc., a Delaware corporation (the “Company”), and Chris Geberth (the “Executive”) and is made effective as of the closing of the transactions contemplated by that certain Business Combination Agreement, dated as of February 9, 2023, by and between the Company, Compute Health Acquisition Corp (“CPUH”), Allurion Technologies Holdings, Inc. (“New Allurion”) and certain other specified parties thereto (the “Business Combination Agreement”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company and any of its subsidiaries regarding the subject matter herein, including, without limitation, the Offer Letter, dated October 23, 2020, by and between the Company and the Executive (the “Prior Agreement”).

EMPLOYMENT AGREEMENT
Employment Agreement • June 27th, 2023 • Allurion Technologies Holdings, Inc. • Surgical & medical instruments & apparatus • Massachusetts

This Employment Agreement (“Agreement”) is made between Allurion Technologies, Inc., a Delaware corporation (the “Company”), and Shantanu Gaur, M.D. (the “Executive”) and is made effective as of the closing of the transactions contemplated by that certain Business Combination Agreement, dated as of February 9, 2023, by and between the Company, Compute Health Acquisition Corp (“CPUH”), Allurion Technologies Holdings, Inc. (“New Allurion”) and certain other specified parties thereto (the “Business Combination Agreement”). Except with respect to the Restrictive Covenants and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company and any of its subsidiaries regarding the subject matter herein, including, without limitation, the Employment Agreement, effective January 1, 2017, by and between the Company and the Executive (the “Prior Agreement”).

EMPLOYMENT AGREEMENT
Employment Agreement • June 27th, 2023 • Allurion Technologies Holdings, Inc. • Surgical & medical instruments & apparatus • Massachusetts

This Employment Agreement (“Agreement”) is made between Allurion Technologies, Inc., a Delaware corporation (the “Company”), and Ram Chuttani, M.D. (the “Executive”) and is made effective as of the closing of the transactions contemplated by that certain Business Combination Agreement, dated as of February 9, 2023, by and between the Company, Compute Health Acquisition Corp (“CPUH”), Allurion Technologies Holdings, Inc. (“New Allurion”) and certain other specified parties thereto (the “Business Combination Agreement”). Except with respect to the Restrictive Covenants and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company and any of its subsidiaries regarding the subject matter herein, including, without limitation, the Employment Agreement, effective November 1, 2017, by and between the Company and the Executive (the “Prior Agreement”).

AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • May 25th, 2023 • Dynatrace, Inc. • Services-prepackaged software • Massachusetts

This Amended and Restated Employment Agreement (“Agreement”) is made between Dynatrace LLC, a Delaware limited liability company, Dynatrace, Inc., the parent of Dynatrace LLC (“Parent”) and Rick McConnell (the “Executive”) and is effective as of March 23, 2023 (the “Effective Date”). Dynatrace LLC, Parent and their respective subsidiaries and other controlled affiliates are collectively referred to herein as the “Company,” and the duties of the Company set forth in this Agreement may be discharged by any entity within that definition.

AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • May 25th, 2023 • Dynatrace, Inc. • Services-prepackaged software • Massachusetts

This Amended and Restated Employment Agreement (“Agreement”) is made between Dynatrace LLC, a Delaware limited liability company, Dynatrace, Inc., the parent of Dynatrace LLC (“Parent”) and Stephen Pace (the “Executive”) and is effective as of March 23, 2023 (the “Effective Date”). Dynatrace LLC, Parent and their respective subsidiaries and other controlled affiliates are collectively referred to herein as the “Company,” and the duties of the Company set forth in this Agreement may be discharged by any entity within that definition.

EMPLOYMENT AGREEMENT
Employment Agreement • March 9th, 2023 • MeridianLink, Inc. • Services-prepackaged software • California

This Employment Agreement (“Agreement”) is made between MeridianLink, Inc., a Delaware corporation (including its successors and assigns, the “Company”), and Sean Blitchok (the “Executive”) and is effective as of May 25, 2022 (the “Effective Date”).

AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • March 9th, 2023 • MeridianLink, Inc. • Services-prepackaged software • California

This Amended and Restated Employment Agreement (“Agreement”) is made between MeridianLink, Inc., a Delaware corporation (including its successors and assigns, the “Company”), and Christopher Maloof (the “Executive”) and is effective as of June 15, 2022 (the “Effective Date”). Except with respect to the Restrictive Covenants Obligations, the Continuing Obligations, and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Employment Agreement between the Executive, Project Angel Parent LLC and the Company (the “Prior Agreement”) and (ii) any offer letter, employment agreement or severance agreement.

EMPLOYMENT AGREEMENT
Employment Agreement • March 9th, 2023 • MeridianLink, Inc. • Services-prepackaged software • California

This Employment Agreement (“Agreement”) is made among Project Angel Parent LLC, a Delaware limited liability company (including its successors and assigns, the “Parent”), MeridianLink, Inc., a California corporation and wholly-owned subsidiary of Parent (including its successors and assigns, the “Company”), and Nicolaas Vlok (the “Executive”) and is effective as of the effectiveness of the Parent’s Form S-1 Registration Statement with the U.S. Securities and Exchange Commission (the “Effective Date”). Except with respect to the Restrictive Covenants Obligations (as modified herein), the Continuing Obligations, and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Parent, the Company, or MeridianLink, Inc., a Delaware corporation regarding the subject matter herein, including without limitation (i) the Employment Agreement between the Executive and MeridianLink, Inc., a Delaware corporation dated Se

EMPLOYMENT AGREEMENT
Employment Agreement • November 21st, 2022 • Dynatrace, Inc. • Services-prepackaged software • Massachusetts

This Employment Agreement (“Agreement”) is made as of November 15, 2022 (the “Effective Date”) between Dynatrace LLC, a Delaware limited liability company, Dynatrace, Inc., the parent of the Company (“Parent”) and Jim Benson (the “Executive”). Dynatrace LLC, Parent and their respective subsidiaries and other controlled affiliates are collectively referred to herein as the “Company,” and the duties of the Company set forth in this Agreement may be discharged by any entity within that definition.

AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • June 16th, 2022 • MeridianLink, Inc. • Services-prepackaged software • California

This Amended and Restated Employment Agreement (“Agreement”) is made between MeridianLink, Inc., a Delaware corporation (including its successors and assigns, the “Company”), and Christopher Maloof (the “Executive”) and is effective as of June 15, 2022 (the “Effective Date”). Except with respect to the Restrictive Covenants Obligations, the Continuing Obligations, and the Equity Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the Employment Agreement between the Executive, Project Angel Parent LLC and the Company (the “Prior Agreement”) and (ii) any offer letter, employment agreement or severance agreement.

FOURTH AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • June 3rd, 2022 • Phreesia, Inc. • Services-business services, nec • New York

This Fourth Amended and Restated Employment Agreement (“Agreement”) is made between Phreesia, Inc., a Delaware corporation (the “Company”), and Thomas Altier (the “Executive”) and is effective as of February 1, 2022.